Bicara Therapeutics Inc. Financial Overview
Bicara Therapeutics Inc.'s market cap is currently $946.08M. The company's EPS TTM is $-0.67; its P/E ratio is -7.75; Bicara Therapeutics Inc. is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
